Short‐Course Subcutaneous Immunotherapy With Mannan‐Conjugated Birch Pollen Allergoids: Consistent Clinical and Immunological Improvements
Study limitation reported by the research below: “The adolescent subgroup (n=13) was too small for reliable conclusions; findings in that group are exploratory only.”